Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 46

1.

A unifying hypothesis of Alzheimer's disease. III. Risk factors.

Heininger K.

Hum Psychopharmacol. 2000 Jan;15(1):1-70.

PMID:
12404343
[PubMed - as supplied by publisher]
2.

A unifying hypothesis of Alzheimer's disease. IV. Causation and sequence of events.

Heininger K.

Rev Neurosci. 2000;11 Spec No:213-328. Review.

PMID:
11065271
[PubMed - indexed for MEDLINE]
3.

The stress system in the human brain in depression and neurodegeneration.

Swaab DF, Bao AM, Lucassen PJ.

Ageing Res Rev. 2005 May;4(2):141-94. Review.

PMID:
15996533
[PubMed - indexed for MEDLINE]
4.

Molecular pathology and pharmacogenomics in Alzheimer's disease: polygenic-related effects of multifactorial treatments on cognition, anxiety and depression.

Cacabelos R.

Methods Find Exp Clin Pharmacol. 2007 Jul;29 Suppl A:1-91. Review.

PMID:
17957277
[PubMed - indexed for MEDLINE]
5.

Redox regulation of heat shock protein expression in aging and neurodegenerative disorders associated with oxidative stress: a nutritional approach.

Calabrese V, Scapagnini G, Colombrita C, Ravagna A, Pennisi G, Giuffrida Stella AM, Galli F, Butterfield DA.

Amino Acids. 2003 Dec;25(3-4):437-44. Epub 2003 Nov 7. Review.

PMID:
14661103
[PubMed - indexed for MEDLINE]
6.

Nutritional antioxidants and the heme oxygenase pathway of stress tolerance: novel targets for neuroprotection in Alzheimer's disease.

Calabrese V, Butterfield DA, Stella AM.

Ital J Biochem. 2003 Dec;52(4):177-81. Review.

PMID:
15141484
[PubMed - indexed for MEDLINE]
7.

How and when environmental agents and dietary factors affect the course of Alzheimer's disease: the "LEARn" model (latent early-life associated regulation) may explain the triggering of AD.

Lahiri DK, Maloney B, Basha MR, Ge YW, Zawia NH.

Curr Alzheimer Res. 2007 Apr;4(2):219-28. Review.

PMID:
17430250
[PubMed - indexed for MEDLINE]
8.

Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.

Calabrese V, Lodi R, Tonon C, D'Agata V, Sapienza M, Scapagnini G, Mangiameli A, Pennisi G, Stella AM, Butterfield DA.

J Neurol Sci. 2005 Jun 15;233(1-2):145-62. Review.

PMID:
15896810
[PubMed - indexed for MEDLINE]
9.

[Genes in Alzheimer's disease].

Hoenicka J.

Rev Neurol. 2006 Mar 1-15;42(5):302-5. Review. Spanish.

PMID:
16538594
[PubMed - indexed for MEDLINE]
Free Article
10.

Genetic heterogeneity of Alzheimer's disease: complexity and advances.

Lambert JC, Amouyel P.

Psychoneuroendocrinology. 2007 Aug;32 Suppl 1:S62-70. Epub 2007 Jul 30. Review.

PMID:
17659844
[PubMed - indexed for MEDLINE]
11.

Involvement of environmental mercury and lead in the etiology of neurodegenerative diseases.

Monnet-Tschudi F, Zurich MG, Boschat C, Corbaz A, Honegger P.

Rev Environ Health. 2006 Apr-Jun;21(2):105-17. Review.

PMID:
16898674
[PubMed - indexed for MEDLINE]
12.

Risk and protective factors for sporadic Alzheimer's disease.

Stozická Z, Zilka N, Novák M.

Acta Virol. 2007;51(4):205-22. Review.

PMID:
18197729
[PubMed - indexed for MEDLINE]
13.

Nitric oxide and cellular stress response in brain aging and neurodegenerative disorders: the role of vitagenes.

Calabrese V, Boyd-Kimball D, Scapagnini G, Butterfield DA.

In Vivo. 2004 May-Jun;18(3):245-67. Review.

PMID:
15341181
[PubMed - indexed for MEDLINE]
Free Article
14.

Pathophysiology of neuronal energy crisis in Alzheimer's disease.

de la Torre JC.

Neurodegener Dis. 2008;5(3-4):126-32. doi: 10.1159/000113681. Epub 2008 Mar 6. Review.

PMID:
18322369
[PubMed - indexed for MEDLINE]
15.

Cholesterol and Alzheimer's disease: clinical and experimental models suggest interactions of different genetic, dietary and environmental risk factors.

Sambamurti K, Granholm AC, Kindy MS, Bhat NR, Greig NH, Lahiri DK, Mintzer JE.

Curr Drug Targets. 2004 Aug;5(6):517-28. Review.

PMID:
15270198
[PubMed - indexed for MEDLINE]
16.

Apolipoprotein E and Alzheimer's disease: molecular mechanisms and therapeutic opportunities.

Cedazo-Mínguez A.

J Cell Mol Med. 2007 Nov-Dec;11(6):1227-38. doi: 10.1111/j.1582-4934.2007.00130.x. Review.

PMID:
18205697
[PubMed - indexed for MEDLINE]
17.

Oxidative stress-induced risk factors associated with the metabolic syndrome: a unifying hypothesis.

Grattagliano I, Palmieri VO, Portincasa P, Moschetta A, Palasciano G.

J Nutr Biochem. 2008 Aug;19(8):491-504. Epub 2007 Sep 12. Review.

PMID:
17855068
[PubMed - indexed for MEDLINE]
18.

Pharmacogenomics and therapeutic prospects in dementia.

Cacabelos R.

Eur Arch Psychiatry Clin Neurosci. 2008 Mar;258 Suppl 1:28-47. doi: 10.1007/s00406-007-1006-x. Review.

PMID:
18344047
[PubMed - indexed for MEDLINE]
19.

Apolipoprotein E4 as a target for developing new therapeutics for Alzheimer's disease.

Refolo LM, Fillit HM.

J Mol Neurosci. 2004;23(3):151-5. Review.

PMID:
15181243
[PubMed - indexed for MEDLINE]
20.

Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review.

Butterfield DA.

Free Radic Res. 2002 Dec;36(12):1307-13. Review.

PMID:
12607822
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk